| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000034528 |
| Receipt No. | R000039369 |
| Scientific Title | The study to examine the relationship between menstrual cycle and skin components in healthy women. |
| Date of disclosure of the study information | 2018/10/18 |
| Last modified on | 2020/04/17 (Ver. 3) |
| Basic information | ||
| Public title | The study to examine the relationship between menstrual cycle and skin components in healthy women. | |
| Acronym | The study to examine the relationship between the menstrual cycle and skin components in healthy women. | |
| Scientific Title | The study to examine the relationship between menstrual cycle and skin components in healthy women. | |
| Scientific Title:Acronym | The study to examine the relationship between the menstrual cycle and skin components in healthy women. | |
| Region |
|
|
| Condition | |||
| Condition | Healthy adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Evaluation of the relationship between the skin components and the menstrual cycle on healthy woman. |
| Basic objectives2 | Others |
| Basic objectives -Others | Observational study for evaluation of the relationship between the skin components and the menstrual cycle on healthy woman. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The relationship between amount of sebum and skin molecules in each menstrual phase, the menstrual, the follicular and the luteal phase. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Panelists who are Japanese females ranging from 20-45 years old. | |||
| Key exclusion criteria | 1.Panelists in irregular menstruation. And, panelists who passed over the menopause.
2.Panelists who has become pregnant and breast-feeding. And, panelists who have a possibility of pregnant during the study period. 3.Panelists with illnesses or diseases which in the opinion of the investigators, might interfere with the conduct of the study or the interpretation of results. Especially panelists with any skin irritation, skin condition (such as rosacea, eczema, atopic dermatitis, or psoriasis), or severe acne on their faces. 4.Panelists who has serious suntan in their faces. 5.Panelists who performs outdoor sport periodically. 6.Panelists who take any OTC or prescription medications, especially anti-inflammation agents, anti-bacterial agents, analgesic agents, hormonal agents, laxative agents, intestinal agents, etc. 7.Panelists who attend the hospital (such as gastrointestinal disease, liver disease, kidney disease, cardiovascular heart disease, skin disease, or poor physical condition). And, panelists for less than one month after attend the hospital. 8.Panelists who has seen in a spa treatment (such as chemical peeling, or laser therapy). And, panelists who has seen in a cosmetic medicine (such as cosmetic surgery, or collagen infusion). 9.Panelists who does not have a trouble in the skin of their face. |
|||
| Target sample size | 56 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Biological Science Research | ||||||
| Zip code | |||||||
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN | ||||||
| TEL | +81-285-68-7461 | ||||||
| inoue.takatoshi@kao.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Biological Science Research | ||||||
| Zip code | |||||||
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN | ||||||
| TEL | +81-285-68-7461 | ||||||
| Homepage URL | |||||||
| nagamori.natsumi@kao.com | |||||||
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | SOUKEN Corporation |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 株式会社SOUKEN(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Evaluation of the relationship between the skin components and the menstrual cycle on healthy woman. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039369 |